US Broker Ratings

Bio-Techne Corp (TECH) Stock Analysis: Navigating Valuation Amidst Sector Dynamics

Bio-Techne Corporation (NASDAQ: TECH), a prominent player in the biotechnology industry, presents a compelling case for investors who are attuned to the healthcare sector’s complex dynamics. With a market capitalization..

Moderna, Inc. (MRNA) Investor Outlook: Navigating a 42.52% Potential Downside Amid Robust Revenue Growth

Moderna, Inc. (MRNA) continues to be a focal point in the biotechnology sector, known for its pioneering work in messenger RNA (mRNA) medicines. The company’s portfolio spans a wide array..

Henry Schein, Inc. (HSIC) Stock Analysis: Navigating Growth in the Medical Distribution Sector with a 1.89% Upside

Henry Schein, Inc. (NASDAQ: HSIC) stands as a formidable player in the healthcare sector, specifically in medical distribution. With a market capitalization of $9.85 billion, the company is a significant..

Fresenius Medical Care AG (FMS) Investor Outlook: Evaluating a 3.70% Dividend Yield Amidst Growth Challenges

Fresenius Medical Care AG (NYSE: FMS) stands as a significant player in the healthcare sector, particularly within the medical care facilities industry. Based in Bad Homburg, Germany, this company specializes..

Halozyme Therapeutics (HALO) Investor Outlook: Analyzing Growth with 42.20% Revenue Surge

Halozyme Therapeutics, Inc. (NASDAQ: HALO) is making waves in the biotechnology sector with its impressive revenue growth and innovative approach to drug delivery. As a United States-based company with a..

Charles River Laboratories Inte (CRL) Stock Analysis: Evaluating Growth Amidst Mixed Financial Metrics

Charles River Laboratories International, Inc. (NYSE: CRL), a key player in the healthcare sector, particularly within the diagnostics and research industry, is capturing investor attention with its broad range of..

Waystar Holding Corp. (WAY) Stock Analysis: Exploring a 42.89% Potential Upside in Healthcare Tech

Investors are keenly eyeing Waystar Holding Corp. (NASDAQ: WAY), as the company is positioned for noteworthy growth within the healthcare technology sector. With a current market capitalization of $4.5 billion,..

STERIS plc (STE) Stock Analysis: Strong Buy Ratings and 17.72% Upside Potential

For investors seeking a robust opportunity in the healthcare sector, STERIS plc (STE) stands out with compelling growth prospects and analyst confidence. This Ireland-based medical devices company, with a significant..

Revvity, Inc. (RVTY) Stock Analysis: Navigating Healthcare Innovation with Modest Growth Potential

Revvity, Inc. (RVTY), a stalwart in the healthcare sector, operates within the diagnostics and research industry, providing indispensable health sciences solutions. Headquartered in Waltham, Massachusetts, Revvity’s extensive product lineup serves..

Waters Corporation (WAT) Stock Analysis: Unlocking a 6% Upside Potential in the Healthcare Sector

Waters Corporation (NYSE: WAT) stands as a formidable player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $37.24 billion, this U.S.-based company..

Repligen Corporation (RGEN) Stock Analysis: A 23.67% Upside Potential Amid Strong Buy Ratings

Repligen Corporation (NASDAQ: RGEN), a key player in the healthcare sector specializing in medical instruments and supplies, is drawing significant attention from investors, thanks to its robust market position and..

GSK plc (GSK) Stock Analysis: Understanding the 5.54% Upside in a Resilient Healthcare Giant

GSK plc (NYSE: GSK), a stalwart in the healthcare sector, presents an intriguing opportunity for investors seeking stability with a touch of growth potential. With a robust market capitalization of..

BeOne Medicines Ltd. (ONC) Stock Analysis: Uncovering a 38.55% Potential Upside in the Biotech Sector

BeOne Medicines Ltd. (ONC), a Swiss-based biotechnology titan, is capturing investor attention with its impressive market cap of $30.88 billion and a potential upside of 38.55%. This oncology-focused company is..

Avantor, Inc. (AVTR) Stock Analysis: Navigating a Healthcare Giant with a $7.05 Billion Market Cap

Avantor, Inc. (AVTR), a stalwart in the healthcare sector, operates within the medical instruments and supplies industry. The company, headquartered in Radnor, Pennsylvania, boasts a substantial market capitalization of $7.05..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Navigating Growth in the Medical Devices Sector

Bio-Rad Laboratories, Inc. (NYSE: BIO), a prominent player in the healthcare sector, specifically within the medical devices industry, presents an intriguing opportunity for investors seeking exposure to the life sciences..

Cardinal Health, Inc. (CAH) Stock Analysis: Stellar Revenue Growth and Analyst Enthusiasm Propel Market Sentiment

Cardinal Health, Inc. (NYSE: CAH), a titan in the healthcare sector, remains a compelling prospect for investors, thanks to its robust revenue growth and favorable analyst ratings. As a leading..

Penumbra, Inc. (PEN) Stock Analysis: A Healthcare Innovator with a 14.40% Potential Upside

Investors with an eye on the healthcare sector might find Penumbra, Inc. (NYSE: PEN) an intriguing option, as the medical device company currently exhibits a notable potential upside of 14.40%..

Koninklijke Philips N.V. (PHG) Stock Analysis: Navigating a 19.90% Potential Upside with Strategic Health Tech Innovations

Koninklijke Philips N.V. (NYSE: PHG), a stalwart in the healthcare sector, is poised for intriguing movement as it sits at the intersection of innovation and financial recalibration. Known for its..

ResMed Inc. (RMD) Stock Analysis: A 24% Upside Potential with Robust Revenue Growth

ResMed Inc. (NYSE: RMD), a key player in the healthcare sector, has been making waves with its innovative solutions in the medical instruments and supplies industry. With a market capitalization..

Exelixis, Inc. (EXEL) Stock Analysis: A Biotech Powerhouse with Strong Revenue Growth and High Analyst Interest

Exelixis, Inc. (NASDAQ: EXEL), a prominent player in the biotechnology sector, continues to capture investor attention with its robust performance metrics and strategic positioning in oncology. With a market capitalization..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds